Skip to search formSkip to main contentSkip to account menu

azumolene

Known as: 1-(((5-(4-bromophenyl)-2-oxazolyl)methylene)amino)-2,4-imidazlidinedione 
National Institutes of Health

Related topics

Related topics

4 relations
Azumolene Sodium

Narrower (1)

EU 4093

Broader (2)

ImidazolesOxazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
Malignant hyperthermia is a pharmacogenetic disease of skeletal muscle in which a life-threatening, hypermetabolic syndrome is… 
2008
2008
Halothane induces vesicular and carrier-mediated release of [3H]serotonin from rat brain cortical slices
2006
2006
Characterization of Ryanodine Receptor–mediated Calcium Release in Human B Cells: Relevance to Diagnostic Testing for Malignant Hyperthermia
Background:Mutations in the ryanodine type 1 receptor (RyR1) are causative for malignant hyperthermia. Studies in human B… 
2005
2005
Effects of Azumolene on Ca2+ Sparks in Skeletal Muscle Fibers
Azumolene is an analog of dantrolene, the only approved medicine for treatment of malignant hyperthermia (MH). The… 
2004
2004
Muscle-relaxing effects of azumolene and dantrolene on different muscle fibers
Objective To evaluate the muscle-relaxing effects of azumolene and dantrolene on the diaphragm,tibialis anterioi and soleus… 
2002
2002
Comparative Effects of Dantrolene and Azumolene on the Contractility of Skeletal and Cardiac Muscles: [2002][A-71]
1999
1999
notropic and Electrophysiologic Effect of Azumolene in Intact Myocardium In Vitro
1992
1992
EU 4093 decreases intracellular [Ca2+] in skeletal muscle fibers from control and malignant hyperthermia-susceptible swine.
The mechanisms causing the malignant hyperthermia (MH) syndrome are related to a malfunction of intracellular Ca2+ homeostasis… 
1990
1990
REVERSAL OF MALIGNANT HYPERTHERMIA EPISODES BY AZUMOLENE IN SUSCEPTIBLE SWINE
1988
1988
AZUMOLENE, A NEW DANTROLENE ANALOGUE, ANTAGONIZES HALOTHANE AND CAFFEINE CONTRACTURESPOTENTIAL FOR USE IN MALIGNANT HYPERTHERMIA
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)